Enhanced water repellent surfaces discovered in nature

Through the investigation of insect surfaces, Penn State researchers have detailed a previously unidentified nanostructure that can be used to engineer stronger, more resilient water repellent coatings.

The results of this research were published today (July 17) in Science Advances.

With an enhanced ability to repel droplets, this design could be applied to personal protective equipment (PPE) to better resist virus-laden particles, such as COVID-19, among other applications.

“For the past few decades, conventionally designed water repellent surfaces have usually been based on plants, like lotus leaves,” said Lin Wang, a doctoral student in the Department of Materials Science and Engineering at Penn State and the lead author of the paper.

Classical engineering theories have used this approach to create superhydrophobic, or water repellent, surfaces. Traditionally, they are manufactured with low solid fraction textures, which maintain an extremely thin layer of air above a low density of microscopic, hair-like nanostructures, which the researchers liken to an air hockey table.

“The reasoning is if the droplet or object is floating on top of that air, it won’t become stuck to the surface,” said Tak-Sing Wong, the Wormley Early Career Professor of Engineering, associate professor of mechanical and biomedical engineering and Wang’s adviser.

Since it works effectively, human-made coatings tend to mimic the low density of these nanostructures.

However, this paper details an entirely different approach. When examining surfaces like the eye of a mosquito, body of a springtail or the wing of a cicada under high resolution electron microscopes, Wang found that the nanoscopic hairs on those surfaces are more densely packed, referred to in engineering as high solid fraction textures. Upon further exploration, this significant departure from plants’ structure may imbue additional water repelling benefits.

“Imagine if you had a high density of these nanostructures on a surface,” Wang said. “It could be possible to maintain the stability of the air layer from higher impact forces.”

This could also mean the more densely packed structures may be able to repel liquid that is moving at a higher speed, such as raindrops.

While the design concept is new to humans, the researchers theorize this nanostructure boosts the insect’s resiliency in its natural environment.

“For these insect surfaces, repelling water droplets is a matter of life and death. The impact force of raindrops is enough to carry them to the ground and kill them,” Wang said. “So, it is really important for them to stay dry, and we figured out how.”

With this knowledge gleaned from nature, the researchers hope to apply this design principle to create next generation coatings. By developing a water repellent surface that can withstand faster moving and higher impact droplets, the applications are abundant.

From small, flying robotic vehicles, such as the drones that Amazon hopes to deliver packages with, to commercial airliners, a coating that can emulate these insect surfaces could provide increased efficiency and safety.

However, in light of the COVID-19 pandemic, researchers have since realized this knowledge could have an additional impact on human health.

“We hope, when developed, this coating could be used for PPE. For example, if someone sneezes around a face shield, those are high velocity droplets. With a traditional coating, those particles could stick to the surface of the PPE,” Wong said. “However, if the design principles detailed in this paper were adopted successfully, it would have the ability to repel those droplets much better and potentially keep the surface germ-free.”

As seen in this work, the Wong Laboratory for Nature Inspired Engineering draws insights from biological phenomena to make humanity’s innovations better and more effective.

“While we didn’t imagine that application at the beginning of this project, COVID-19 made us think about how we can use this design principle to benefit more people,” Wong said. “It’s up to us as engineers to take these discoveries and apply them in a meaningful way.”

The next step for this work will be developing a large scale, cost effective method that can manufacture a coating to mimic these properties.

“In the past, we didn’t have an effective surface that could repel high speed water droplets,” Wong said. “But the insects told us how. There are so many examples like this in nature; we just need to be learning from them.”

This research was funded by the National Science Foundation, the PPG Foundation, the Wormley Family Early Career Professorship, the Humanitarian Materials Initiative Award sponsored by Covestro and the Materials Research Institute at Penn State. Additional contributors include Ruoxi Wang, an undergraduate alumna, and Jing Wang, a doctoral graduate, both in the Department of Mechanical Engineering.

Share Button

Health24.com | Exercise might make breast milk’s goodness even better

  • Babies who receive a certain compound when breastfed are less likely to experience chronic illness later in life
  • This compound is called 3SL and is present in the milk of mothers who get enough exercise
  • If 3SL can be isolated, it could be included in infant formula or supplements to benefit babies 

Exercise is part of a healthy lifestyle, but a new study suggests it also increases the amount of a beneficial compound called 3SL in the breast milk of both humans and mice.

Based on that, researchers think that its benefits to babies could last for decades, potentially making them less likely to experience such chronic illnesses as obesity, type 2 diabetes and heart disease as they age.

“As long as they were given 3SL during their nursing period, they were protected as they aged,” said Kristin Stanford, who led the mouse portion of the study at Ohio State University’s Wexner Medical Center. “In the absence of any self-intervention, this has absolutely provided a really strong protective effect.”

Though past studies have shown the benefit of maternal exercise to offspring, this study begins to answer the question of why, Stanford said.

The more steps, the better

The human side of the research was led by Aline Andres at Arkansas Children’s Nutrition Center and included 150 pregnant and postpartum women who used activity trackers to count their steps. The women then provided samples of breast milk, which researchers analysed.

Mothers whose trackers had recorded even a moderate number of steps showed a greater amount of 3SL in their breast milk, without considering exercise intensity. And more steps showed even greater levels of 3SL in the women.

Andrea Berardi was one of those women. The Ohio resident has always enjoyed exercise, running marathons and doing deep-stretch yoga classes, so continuing to stay active during pregnancy came naturally. Now the mom of a 6-month-old daughter, she joined the study right after her daughter was born.

Though Berardi initially thought she would breastfeed her daughter for six months, her goal now is one year. To think that what she’s doing now could enhance her daughter’s health for years to come is amazing, she said.

“So many people want to give their children the best step forward and do everything that’s best for them,” Berardi said. “Anything to help her bypass those major issues in her medical charts, that’s obviously a goal of mine.”

Improved glucose metabolism

Stanford was thrilled to see the human findings mirrored what her team saw in mice.

“It was really exciting for us to have them do the study in a totally different institution and see the same thing that we had seen in mice that they were seeing in humans,” said Stanford, who is an associate professor of physiology and cell biology at Ohio State’s Dorothy M. Davis Heart and Lung Research Institute.

The research was published on 29 June in the journal Nature Metabolism and also included scientists from the University of California, San Diego, and the Joslin Diabetes Center in Boston.

In mice, researchers found the offspring of those who exercised had reduced fat mass or body weight, as well as improved glucose metabolism, Stanford said. When other mouse pups were given the breast milk of the exercise-trained mice, they showed these same benefits.

“This showed that the milk is definitely an important factor in that,” Stanford said. “It was really enough to contribute to these overall metabolic effects.”

Even when the mouse pups were fed a high-fat diet later, they still had improved metabolism, cardiac function and body composition. The increased 3SL in breast milk for moms who were more active held true, even if the moms were overweight.

‘Breast milk is remarkable’

“It didn’t really matter what your starting BMI [body mass index] was or your starting body weight, as long as you were moving, we saw these effects,” Stanford said.

“If something as simple as increasing your steps per day while you’re pregnant can protect your child from some of these things or even have a minimal effect on how they develop in a positive way, I think that the implications for public health can be pretty dramatic,” Stanford added. But the study could not prove that exercise actually caused 3SL levels to rise.

Researchers also are examining whether they can isolate 3SL for potential future inclusion in infant formula or infant supplements.

Breast milk is remarkable, said Connie Diekman, a food nutrition consultant in St. Louis.

“The validation of this study is what we have long said, that breast is best,” Diekman said. “It is that foundation that it lays for the rest of life that is so vitally important and that we don’t fully understand.

“It appears even if a mom can do it for six weeks or two months, that infant gets a very significant benefit for the rest of their lives,” she added.

For mothers who may not be able to breastfeed or who choose not to, “you still can provide your infant a well-balanced, healthful eating plan,” Diekman said.

Image credit: iStock

NEXT ON HEALTH24X

Share Button

Coronavirus: Cuts ‘took away’ councils’ crisis capacity

Chief Medical Officer Chris Whitty called for honesty about the lack of investment in health protection in recent years.

Share Button

Researchers create a roadmap to better multivalent batteries

Lithium-ion batteries are recognized for their high energy density in everything from mobile phones to laptop computers and electric vehicles, but as the need for grid-scale energy storage and other applications becomes more pressing, researchers have sought less expensive and more readily available alternatives to lithium.

Batteries using more abundant multivalent metals could revolutionize energy storage. Researchers review the current state of multivalent metal-ion battery research and provide a roadmap for future work in Nature Energy, reporting that the top candidates — using magnesium, calcium, zinc and aluminum — all have great promise, but also steep challenges to meet practical demands.

“In this review, we clarify the key strengths as well as common misconceptions of multivalent metal-based batteries,” said Yan Yao, Cullen College of Engineering associate professor of electrical and computer engineering at the University of Houston and co-corresponding author of the paper. “Multivalent metal-ion batteries are better viewed as alternative solutions for large-scale energy storage than as a direct competitor to lithium-based batteries in the race toward ever-rising energy density targets.”

Researchers also examined the growth behavior of metal anodes. While magnesium is a promising material, Yao said it is important to note that it is not guaranteed to plate universally in dendrite-free morphology. “It only does so in selected electrolyte solutions where there are no side reactions, the active metal surface is free of passivation, and the coulombic efficiency of magnesium plating?stripping is close to unity,” he said.

Yao is also a principal investigator with the Texas Center for Superconductivity at UH (TcSUH).

Yanliang “Leonard” Liang, a research assistant professor in the Department of Electrical and Computer Engineering at UH and co-first author, said the paper’s review of existing cathode materials also offers new insights. “We also discuss design strategies to enable genuine multivalent metal-ion-based energy storage materials with competitive performance,” he said.

Researchers’ key points include:

  • Concerns about the availability and cost of lithium have prompted interest in alternative battery technologies that use more abundant elements with the potential for higher energy density and enhanced safety. Prime candidates include magnesium, calcium, zinc and aluminum, all of which are known as multivalent metals, or metals with multiple valence electrons to give
  • These multivalent metal-ion batteries share many similarities in working principles with lithium-ion batteries, suggesting they could be swiftly adopted by industry
  • Previous assessments of the anticipated energy density of these batteries often considered only the multivalent metal anode — merely one of the two electrodes in a battery — which tends to reach misleading conclusions. The researchers have provided a reassessment of the energy density based on both anode and cathode, aiming to better position these batteries in the energy storage landscape
  • Direct use of metals as anodes is an important aspect for the safety and energy density promises of these batteries, but there are uncertainties surrounding the viability of these anodes
  • Electrolyte solutions and understanding of the associated interfacial phenomena are improving but still far from established
  • And finding good cathode materials requires considerations that are uncommon in traditional battery studies. The ion storage mechanism of multivalent battery cathodes is much more complicated than its lithium-ion counterpart.
  • Misinterpretation of the cathode chemistry is surprisingly widespread in the literature as a result

The researchers also issued a list of recommendations to ensure future research is squarely directed at improving the batteries, including:

  • Gaining a better understanding of the growth behavior of the metal anodes, a critical step in realizing the purported safety promises over lithium-ion batteries
  • Practices to properly assess the compatibility of metal anodes with electrolyte solutions and the effectiveness of protection coatings
  • Procedures and techniques to correctly interpret the ion storage mechanism at the cathode
  • Approaches to design better cathode materials

A table comparing the state-of-the-art components — metal anode, electrolyte and cathode materials — for batteries based on each of the multivalent metal elements that could potentially replace lithium found that although some are further along than others, none of the options are ready for commercialization.

Yao’s research group has focused on materials chemistry and design of magnesium and other multivalent metal batteries; he has published widely in top journals.

Story Source:

Materials provided by University of Houston. Original written by Jeannie Kever. Note: Content may be edited for style and length.

Share Button

Cannabis shows potential for mitigating sickle cell disease pain

Cannabis appears to be a safe and potentially effective treatment for the chronic pain that afflicts people with sickle cell disease, according to a new clinical trial co-led by University of California, Irvine researcher Kalpna Gupta and Dr. Donald Abrams of UC San Francisco. The findings appear in JAMA Network Open.

“These trial results show that vaporized cannabis appears to be generally safe,” said Gupta, a professor of medicine on the faculty of UCI’s Center for the Study of Cannabis. “They also suggest that sickle cell patients may be able to mitigate their pain with cannabis — and that cannabis might help society address the public health crisis related to opioids. Of course, we still need larger studies with more participants to give us a better picture of how cannabis could benefit people with chronic pain.”

Opioids are currently the primary treatment for the chronic and acute pain caused by sickle cell disease. But the rise in opioid-associated deaths has prompted physicians to prescribe them less frequently, leaving sickle cell patients with fewer options.

The double-blind, placebo-controlled, randomized trial was the first to employ such gold-standard methods to assess cannabis’s potential for pain alleviation in people with sickle cell disease. The cannabis used in the trial was obtained from the National Institute on Drug Abuse — part of the National Institutes of Health — and contained equal parts of THC and CBD.

“Pain causes many people to turn to cannabis and is, in fact, the top reason that people cite for seeking cannabis from dispensaries,” Gupta said. “We don’t know if all forms of cannabis products will have a similar effect on chronic pain. Vaporized cannabis, which we employed, may be safer than other forms because lower amounts reach the body’s circulation. This trial opens the door for testing different forms of medical cannabis to treat chronic pain.”

Twenty-three patients with sickle cell disease-related pain completed the trial, inhaling vaporized cannabis or a vaporized placebo during two five-day inpatient sessions that were separated by at least 30 days. This allowed them to act as their own control group.

Researchers assessed participants’ pain levels throughout the treatment period and found that the effectiveness of cannabis appeared to increase over time. As the five-day study period progressed, subjects reported that pain interfered less and less with activities, including walking and sleeping, and there was a statistically significant drop in how much pain affected their mood. Although pain levels were generally lower in patients given cannabis than in those given the placebo, the difference was not statistically significant.

Story Source:

Materials provided by University of California – Irvine. Note: Content may be edited for style and length.

Share Button

Coronavirus: Rochdale introduces new Covid-19 measures

The council is urging residents to follow extra precautions to avoid a local lockdown.

Share Button

New insight into the origin of water on Earth

Scientists have found the interstellar organic matter could produce an abundant supply of water by heating, suggesting that organic matter could be the source of terrestrial water.

There remains a number of mysteries on our planet including the elusive origin of water on the earth. Active studies suggested that terrestrial water had been delivered by icy comets or meteorites containing hydrous silicates that came from outside the “snow line” — the boundary beyond which ice can condense due the low temperatures. More recent studies, however, have provided observations opposing to cometary origin theory, yet still failing to suggest plausible substitutions for the source of terrestrial water. “Until now, much less attention has been paid to organic matter, comparing to ices and silicates, even though there is an abundance inside the snow line” says planetary scientist Akira Kouchi at Hokkaido University.

In the recent study published in Scientific Reports, a group of scientists led by Akira Kouchi demonstrates that heating of the interstellar organic matter at high temperature could yield abundant water and oil. This suggests that water could be produced inside the snow line, without any contribution of comets or meteorites delivered from outside the snow line.

As a first step, the researchers made an analog of organic matter in interstellar molecular clouds using chemical reagents. To make the analog, they referred to analytical data of interstellar organics made by irradiating UV on a mixture containing H2O, CO, and NH3, which mimicked its natural synthetic process. Then, they gradually heated the organic matter analog from 24 to 400 ? under a pressured condition in a diamond anvil cell. The sample was uniform until 100 ?, but was separated into two phases at 200 ?. At approximately 350 ?, the formation of water droplets became evident and the sizes of the droplets increased as the temperature rose. At 400 ?, in addition to water droplets, black oil was produced.

The group conducted similar experiments with larger amounts of organic matter, which also yielded water and oil. Their analysis of absorption spectra revealed that the main component of the aqueous product was pure water. Additionally, chemical analysis of produced oil showed similar characteristics to the typical crude oil found beneath the earth.

“Our results show that the interstellar organic matter inside the snow line is a potential source of water on the earth. Moreover, the abiotic oil formation we observed suggests more extensive sources of petroleum for the ancient Earth than previously thought,” says Akira Kouchi. “Future analyses of organic matter in samples from the asteroid Ryugu, which the Japan’s asteroid explorer Hayabusa2 will bring back later this year, should advance our understanding of the origin of terrestrial water.”

Story Source:

Materials provided by Hokkaido University. Note: Content may be edited for style and length.

Share Button

Antarctica more widely impacted by humans than previously thought

Antarctica is considered one of the Earth’s largest, most pristine remaining wildernesses. Yet since its formal discovery 200 years ago, the continent has seen accelerating and potentially impactful human activity.

How widespread this activity is across the continent has never been quantified. We know Antarctica has no cities, agriculture or industry. But we have never had a good idea of where humans have been, how much of the continent remains untouched or largely unimpacted, and to what extent these largely unimpacted areas serve to protect biodiversity.

A team of researchers led by Monash University, including Dr Bernard Coetzee from the Global Change Institute at the University of the Witwatersrand, Johannesburg (Wits University), has changed all of that. Using a data set of 2.7 million human activity records, the team showed just how extensive human use of Antarctica has been over the last 200 years. The research was published in the journal Nature.

With the exception of some large areas mostly in the central parts of the continent, humans have set foot almost everywhere.

Although many of these visited areas have only been negligibly affected by people, biodiversity is not as well represented within them as it should be.

“We mapped 2.7 million human activity records from 1819 to 2018 across the Antarctic continent to assess the extent of wilderness areas remaining and its overlap with the continent’s biodiversity,” says Coetzee, a conservation scientist at Wits University. Based in Skukuza in the Kruger National Park in South Africa, Coetzee helped conceptualise the study and collated a spatial database from multiple sources to map the extent of human activity in Antarctica.

“In a region often thought of as remote, we showed that in fact human activity has been extensive, especially in ice-free and coastal areas where most of its biodiversity is found. This means that “wilderness” areas do not capture many of the continent’s important biodiversity sites, but that an opportunity exists to conserve the last of the wild.”

The study found that only 16% of the continent’s Important Bird Areas, areas identified internationally as critical for bird conservation, are located within negligibly impacted areas, and little of the total negligibly impacted area is represented in Antarctica’s Specially Protected Area network.

High human impact areas, for example some areas where people build research stations or visit for tourism, often overlap with areas important for biodiversity.

Lead author, Rachel Leihy, a PhD student in the Monash School of Biological Sciences, points out that “While the situation does not look promising initially, the outcomes show that much opportunity exists to take swift action to declare new protected areas for the conservation of both wilderness and biodiversity.”

“Informatics approaches using large data sets are providing new quantitative insights into questions that have long proven thorny for environmental policymakers,” says Steven Chown, the corresponding author based at Monash University.

“This work offers innovative ways to help the Antarctic Treaty Parties take forward measures to secure Antarctica’s Wilderness.”

The transdisciplinary team delivering this work includes researchers from Australia, the Netherlands, New Zealand, and South Africa.

Share Button

Breakthrough blood test detects positive COVID-19 result in 20 minutes

New research by Monash University in Australia has been able to detect positive COVID-19 cases using blood samples in about 20 minutes, and identify whether someone has contracted the virus.

In a discovery that could advance the worldwide effort to limit the community spread of COVID-19 through robust contact tracing, researchers were able to identify recent COVID-19 cases using 25 microlitres of plasma from blood samples.

The research team, led by BioPRIA and Monash University’s Chemical Engineering Department, including researchers from the ARC Centre of Excellence in Convergent BioNano Science and Technology (CBNS), developed a simple agglutination assay — an analysis to determine the presence and amount of a substance in blood — to detect the presence of antibodies raised in response to the SARS-CoV-2 infection.

Positive COVID-19 cases caused an agglutination or a clustering of red blood cells, which was easily identifiable to the naked eye. Researchers were able to retrieve positive or negative readings in about 20 minutes.

While the current swab / PCR tests are used to identify people who are currently positive with COVID-19, the agglutination assay can determine whether someone had been recently infected once the infection is resolved — and could potentially be used to detect antibodies raised in response to vaccination to aid clinical trials.

Using a simple lab setup, this discovery could see medical practitioners across the world testing up to 200 blood samples an hour. At some hospitals with high-grade diagnostic machines, more than 700 blood samples could be tested hourly — about 16,800 each day.

Study findings could help high-risk countries with population screening, case identification, contact tracing, confirming vaccine efficacy during clinical trials, and vaccine distribution.

This world-first research was published July 18, 2020, in the journal ACS Sensors.

A patent for the innovation has been filed and researchers are seeking commercial and government support to upscale production.

Dr Simon Corrie, Professor Gil Garnier and Professor Mark Banaszak Holl (BioPRIA and Chemical Engineering, Monash University), and Associate Professor Timothy Scott (BioPRIA, Chemical Engineering and Materials Science and Engineering, Monash University) led the study, with initial funding provided by the Chemical Engineering Department and the Monash Centre to Impact Anti-microbial Resistance.

Dr Corrie, Senior Lecturer in Chemical Engineering at Monash University and Chief Investigator in the CBNS, said the findings were exciting for governments and health care teams across the world in the race to stop the spread of COVID-19. He said this practice has the potential to become upscaled immediately for serological testing.

“Detection of antibodies in patient plasma or serum involves pipetting a mixture of reagent red blood cells (RRBCs) and antibody-containing serum/plasma onto a gel card containing separation media, incubating the card for 5-15 minutes, and using a centrifuge to separate agglutinated cells from free cells,” Dr Corrie said.

“This simple assay, based on commonly used blood typing infrastructure and already manufactured at scale, can be rolled out rapidly across Australia and beyond. This test can be used in any lab that has blood typing infrastructure, which is extremely common across the world.”

Researchers collaborated with clinicians at Monash Health to collect blood samples from people recently infected with COVID-19, as well as samples from healthy individuals sourced before the pandemic emerged.

Tests on 10 clinical blood samples involved incubating patient plasma or serum with red blood cells previously coated with short peptides representing pieces of the SARS-CoV-2 virus.

If the patient sample contained antibodies against SARS-CoV-2, these antibodies would bind to peptides and result in aggregation of the red blood cells. Researchers then used gel cards to separate aggregated cells from free cells, in order to see a line of aggregated cells indicating a positive response. In negative samples, no aggregates in the gel cards were observed.

“We found that by producing bioconjugates of anti-D-IgG and peptides from SARS-CoV-2 spike protein, and immobilising these to RRBCs, selective agglutination in gel cards was observed in the plasma collected from patients recently infected with SARS-CoV-2 in comparison to healthy plasma and negative controls,” Professor Gil Garnier, Director of BioPRIA, said.

“Importantly, negative control reactions involving either SARS-CoV-2-negative samples, or RRBCs and SARS-CoV-2-positive samples without bioconjugates, all revealed no agglutination behaviour.”

Professor Banaszak Holl, Head of Chemical Engineering at Monash University, commended the work of talented PhD students in BioPRIA and Chemical Engineering who paused their projects to help deliver this game changing COVID-19 test.

“This simple, rapid, and easily scalable approach has immediate application in SARS-CoV-2 serological testing, and is a useful platform for assay development beyond the COVID-19 pandemic. We are indebted to the work of our PhD students in bringing this to life,” Professor Banaszak Holl said.

“Funding is required in order to perform full clinical evaluation across many samples and sites. With commercial support, we can begin to manufacture and roll out this assay to the communities that need it. This can take as little as six months depending on the support we receive.”

COVID-19 has caused a worldwide viral pandemic, contributing to nearly 600,000 deaths and more than 13.9 million cases reported internationally (figures dated 17 July 2020).

Share Button

Health24.com | Dangerous antibiotic-resistant bacteria may now lurk in US water and soil

  • A dangerous bacterium that can cause lung failure may now be found in the US
  • The infection is called melioidosis and was previously contracted only in countries outside America
  • Because there’s no vaccine, and the disease doesn’t respond to most antibiotics, it’s often fatal

Potentially deadly antibiotic-resistant bacteria could be hiding in the dirt and water of the southernmost US states, warns a new report from the US Centers for Disease Control and Prevention.

The bacterial infection, called melioidosis, caused the lungs of a 63-year-old Texan to shut down in late 2018, forcing doctors to put him on a ventilator to save his life, the researchers said.

US citizens who’ve caught melioidosis in the past typically picked it up in a foreign country, but this man had not recently travelled abroad, said Johanna Salzer, a veterinary medical officer with the CDC’s Bacterial Special Pathogens Branch.

What’s more, the bacteria that caused the man’s melioidosis were genetically similar to two prior US cases, one in Texas in 2004 and one in Arizona in 1999.

Resistant to many antibiotics

“We feel like this is evidence that it could be in the environment” in the United States, Salzer said. “We just need to find it.”

Melioidosis is caused by the bacteria Burkholderia pseudomallei. Humans pick up the bacteria by inhaling dust or tiny droplets of water, or by dirt or water getting into an open wound, Salzer said.

There are an estimated 160 000 cases of melioidosis every year around the world, and 89 000 deaths, “which is really high for a disease a lot of people don’t know about,” Salzer said. It most commonly kills through blood poisoning or respiratory failure.

The fatality rate is estimated to exceed 70% if a person sick with melioidosis is left untreated, Salzer said.

There’s no vaccine for the bacterium, and it is naturally resistant to many commonly used antibiotics. These include penicillin, ampicillin, cephalosporins, gentamicin, tobramycin and streptomycin, the researchers said.

Patients often require at least two weeks of IV drugs followed by several months of oral antibiotics to wipe out the infection.

On antibiotics for three months

The man, from Atascosa County, Texas, went to the hospital in November 2018. He’d had fever, chest pain and shortness of breath for three days, according to the report in the June issue of the CDC journal Emerging Infectious Diseases.

Doctors diagnosed him with pneumonia, and a blood test revealed a B. pseudomallei infection. He subsequently developed a large ulcer on his chest.

Four days after admission to the hospital, the man stopped breathing and was put on a ventilator. He was transferred to another hospital, which switched him to an antibiotic that was more effective against the bacteria.

The patient left the hospital after three weeks, but remained on daily antibiotics for another three months, according to the report. The disease also injured his kidney, which required dialysis three times a week.

These bacteria are most commonly found in the tropical climates of Southeast Asia, South and Central America, and northern Australia. It also has been detected in two US territories, Puerto Rico and the US Virgin Islands, Salzer said.

Tough to diagnose

Previously, B. pseudomallei “has never been found in the environment in the continental United States,” Salzer said.

Unfortunately, the handful of cases cited by the researchers seem to indicate that the bacteria might have made a home for themselves in the southern United States.

“There is global modelling that the bacteria could survive, and survive well, in Texas and areas of Florida,” Salzer said.

The CDC plans to partner with academic institutions to search for the bacteria in the continental United States, in much the same way that it was uncovered in Puerto Rico and the Virgin Islands, Salzer said.

Melioidosis can be tough to diagnose, Salzer said.

“It’s been called the Great Mimicker or the Imitator Disease,” Salzer said. “If you’re not looking for it, it doesn’t have really clear and reliable symptoms in all people.”

Many have diabetes

Symptoms also can take months or years to develop, making it even more difficult for doctors to puzzle out their patient’s illness, the report added.

The CDC experts urge doctors to test for the presence of the bacteria in patients in the southwestern United States who:

  • Have symptoms that seem to indicate pneumonia, blood infection, skin lesions or internal organ abscesses
  • Have chronic diseases that put them at increased risk for dangerous infections, especially diabetes or kidney disease
  • Don’t improve after treatment with commonly used antibiotics

More than 60% of melioidosis patients have diabetes, including the man in Texas, Salzer said.

Dr Robert Glatter is an emergency medicine physician with Lenox Hill Hospital in New York City. “Lack of an international travel history should not rule out a diagnosis of melioidosis. People who also travel to the southwest US are consequently at increased risk,” he said.

“Increased healthcare provider awareness and education regarding the geographical distribution of this disease along with risk factors and pitfalls for managing melioidosis can help reduce mortality,” Glatter added.

Image credit: iStock

NEXT ON HEALTH24X

Share Button